Showing 1-10 of 17 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Pro-Angiogenic and Immune-Modulatory Scaffolds for the Functional Engraftment of Islets in the Subcutaneous Space | Carnegie Mellon University | Adam Feinberg | Cures | 01-November-2024 to 31-October-2027 | $950,000.00 |
| Local bioelectronic oxygenation for islet engraftment | Carnegie Mellon University | Tzahi Cohen-Karni | Cures | 01-August-2024 to 31-July-2027 | $974,998.74 |
| Leveraging humoral immunity to promote commensal microbial protection from T1D | Children’s Hospital of Philadelphia | Michael Silverman | Cures | 01-May-2020 to 30-April-2026 | $749,994.60 |
| Development of a tolerogenic hydrogel depot for islet cell protection | Drexel University | Christopher Rodell | Cures | 01-November-2026 to 31-October-2029 | $614,379.18 |
| Using genetics to better diagnose and treat adult-onset T1D in multi-ethnic US population | Geisinger Clinic | David Carey | Cures | 01-November-2022 to 30-September-2026 | $1,469,640.10 |
| Early identification strategies to assist with prevention of eating disorders (insulin restriction) in Type 1 diabetes | Penn State College of Medicine | Heather Stuckey | Improving Lives | 01-October-2023 to 31-December-2026 | $488,976.45 |
| Inhibition of REDD1 Allostery as a Therapeutic for Type 1 Diabetes | Penn State College of Medicine | Michael Dennis | Improving Lives | 01-June-2024 to 31-May-2026 | $200,000.00 |
| Engineering regulatory B cells to promote immune tolerance for islet cell replacement therapy: A novel opportunity to cure Type I diabetes | Trustees of the University of Pennsylvania | James Markmann | Cures | 01-October-2026 to 30-September-2029 | $598,995.17 |
| Evaluating gene-modified hypo-immune PSCs for immune evasion in NHPs | Trustees of the University of Pennsylvania | Ji Lei | Cures | 01-June-2025 to 31-May-2027 | $749,999.08 |
| A bioelectronics platform to standardize SC-islet maturation and model T1D autoimmunity | Trustees of the University of Pennsylvania | Juan Alvarez | Cures | 01-October-2026 to 30-September-2029 | $1,049,999.94 |